Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Clinical trial NCT04625595 · COMPLETED
Trial details
- NCT number
- NCT04625595
- Sponsor
- Immunomolecular Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2021-05-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.